HemOnc Today honors Next Gen Innovators at ASCO
Click Here to Manage Email Alerts
HemOnc Today unveiled its second class of Next Gen Innovators during ASCO Annual Meeting.
The publication’s 71 Next Gen Innovators — which include clinicians and researchers who specialize in solid tumors, hematologic malignancies and benign hematology — are a highly select group of early career hematologists and oncologists who have advanced their field through innovative approaches in the clinical and research settings.
HemOnc Today Editorial Board Members, along with other leaders in the field, nominated exceptional individuals for this honor.
The Next Gen Innovators initiative — launched in December 2017 — will help showcase the talents and expertise of these rising stars in hematology and oncology by giving them a voice in HemOnc Today’s coverage.
Honorees will provide perspective on studies presented at major scientific meetings or published in peer-reviewed literature. They also will serve as sources for staff-written news articles, giving them an opportunity to share their views about research advances in their field and the challenges they face in their specialty.
“We would like to congratulate the members of the Next Gen Innovators and thank them for all of their individual accomplishments and contributions to the specialty,” said Joan-Marie Stiglich, ELS, Chief Content Officer of SLACK Incorporated, the publisher of HemOnc Today. “We look forward to working with this unique group of early career hematologists and oncologists to help bring a broader scope and perspective to our readers. It’s another step in our ongoing commitment to the entire hematology and oncology community.”
Here is a list of all HemOnc Today Next Gen Innovators:
Allistair Abraham, MD
Children’s National Health System
George Washington University
Foluso O. “Bisi” Ademuyiwa, MD, MPH, MSCI
Washington University School of Medicine in St. Louis
Rahul Aggarwal, MD
Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco
Ibrahim T. Aldoss, MD
City of Hope
Mara B. Antonoff, MD, FACS
The University of Texas MD Anderson Cancer Center
Andrea B. Apolo, MD
National Cancer Institute
Matthew J. Barth, MD
Roswell Park Comprehensive Cancer Center
University at Buffalo
Afsaneh Barzi, MD, PhD
Keck School of Medicine of USC
USC Norris Comprehensive Cancer Center
Aarti Bhatia, MD, MPH
Yale Cancer Center
Giada Bianchi, MD
Dana-Farber Cancer Institute
Kim A. Reiss Binder, MD
University of Pennsylvania
Yanis Boumber, MD, PhD
Fox Chase Cancer Center
Andrew M. Brunner, MD
Massachusetts General Hospital
Harvard Medical School
Huynh Cao, MD
Loma Linda University Health
George Chen, MD
Roswell Park Comprehensive Cancer Center
University at Buffalo
Amy Comander, MD
Auerbach Breast Center
Newton-Wellesley Hospital
Massachusetts General Hospital Cancer Center
Harvard Medical School
Adam C. Cuker, MD, MS
University of Pennsylvania
Siddhartha Devarakonda, MD
Washington University School of Medicine in St. Louis
Efrat Dotan, MD
Fox Chase Cancer Center
Narjust Duma, MD
Mayo Clinic
Rochester, Minn.
Andrew Dunbar, MD
Memorial Sloan Kettering Cancer Center
Areej El-Jawahri, MD
Massachusetts General Hospital
Harvard Medical School
Pauline Funchain, MD
Cleveland Clinic Taussig Cancer Institute
Ignacio Garrido-Laguna, MD, PhD
Huntsman Cancer Institute
The University of Utah
Lindsey A. George, MD
University of Pennsylvania
Children’s Hospital of Philadelphia
Aaron T. Gerds, MD, MS
Cleveland Clinic Taussig Cancer Institute
Damian J. Green, MD
University of Washington
Fred Hutchinson Cancer Research Center
Nicole R. Grieselhuber, MD, PhD
The Ohio State University
Elizabeth A. Griffiths, MD
Roswell Park Comprehensive Cancer Center
University at Buffalo
Michael R. Grunwald, MD
Levine Cancer Institute
Atrium Health
Diana Hanna, MD
Keck School of Medicine of USC
USC Norris Comprehensive Cancer Center
Gabriela S. Hobbs, MD
Massachusetts General Hospital
Laura E. Hogan, MD
Stony Brook University
Kunal C. Kadakia, MD, FACP
Levine Cancer Institute
Atrium Health
The University of North Carolina at Chapel Hill
Julie Kanter, MD
Medical University of South Carolina
Kedar Kirtane, MD
University of Washington
Fred Hutchinson Cancer Research Center
Christopher A. Klebanoff, MD
Parker Institute for Cancer Immunotherapy
Memorial Sloan Kettering Cancer Center
Weill Cornell Medicine
Dan Landau, MD, PhD
Weill Cornell Medicine
New York Genome Center
Richard J. Lee, MD, PhD
Massachusetts General Hospital
Harvard Medical School
Jose Pablo Leone, MD
Dana-Farber Cancer Institute
Daneng Li, MD
City of Hope
Gabriel Mannis, MD
Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco
Benjamin Maughan, MD, PharmD
Huntsman Cancer Institute
The University of Utah
Van Morris, MD, MS
The University of Texas MD Anderson Cancer Center
Rakhi P. Naik, MD, MHS
Johns Hopkins Medicine
Vivek Narayan, MD, MSCE
University of Pennsylvania
Aziz Nazha, MD
Cleveland Clinic Taussig Cancer Institute
Ryan Nipp, MD, MPH
Massachusetts General Hospital
Harvard Medical School
Ifeyinwa Osunkwo, MD, MPH
Levine Cancer Institute
Atrium Health
The University of North Carolina at Chapel Hill
Taofeek Owonikoko, MD, PhD, MSCR
Winship Cancer Institute
Emory University
Steven Park, MD
Levine Cancer Institute
Atrium Health
The University of North Carolina at Chapel Hill
Sapna Pradyuman Patel, MD
The University of Texas MD Anderson Cancer Center
Lindsay L. Peterson, MD, MSCR
Washington University School of Medicine in St. Louis
Zofia Piotrowska, MD, MHS
Massachusetts General Hospital Cancer Center
Vinay K. Prasad, MD, MPH
Oregon Health & Science University
Pedram Razavi, MD, PhD
Memorial Sloan Kettering Cancer Center
Mohamed E. Salem, MD
Levine Cancer Institute
Atrium Health
Mina S. Sedrak, MD, MS
City of Hope
Deva Sharma, MD, MS
Vanderbilt University
Nicholas Short, MD
The University of Texas MD Anderson Cancer Center
Surbhi Sidana, MD
Mayo Clinic
Rochester, Minn.
Eric L. Smith, MD, PhD
Memorial Sloan Kettering Cancer Center
Davendra P.S. Sohal, MD, MPH
Cleveland Clinic Taussig Cancer Institute
Deborah M. Stephens, DO
Huntsman Cancer Institute
The University of Utah
Carlyn Tan, MD
Fox Chase Cancer Center
Sara Tolaney, MD, MPH
Harvard Medical School
Dana-Farber Cancer Institute
Pallawi Torka, MD
Roswell Park Comprehensive Cancer Center
Katy K. Tsai, MD
Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco
Eduardo Vilar-Sanchez, MD, PhD
The University of Texas MD Anderson Cancer Center
Jeffrey P. Ward, MD, PhD
Washington University School of Medicine in St. Louis
Jason C. Ye, MD
Keck School of Medicine of USC
USC Norris Comprehensive Cancer Center
Nominations may be sent to Editorial Director Mark Leiser at mleiser@healio.com.